SAS, global leaders in business intelligence solutions, on Friday announced setting up of its largest research and development centre in Pune, as it expects the Indian market to grow by 27 per cent and generate $87.4 billion worth business by 2009.
The 344 banned drugs include the fixed dose combination of Chlopheniramine Maleate and Codeine syrup sold under the popular cough syrup brand Corex.
The popular anti-impotence drug will be available in about 2,000 drugstores in major cities.
Ranbaxy Laboratories has received tentative approval form the Food & Drug Administration USA for manufacturing and marketing Fluconazole tablets
Investors must carefully watch the developments on the MNC pipeline.
Take the Rediff Business Quiz and find out how much you know about some of the world's major companies.
The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.
Ten months after new Sebi norms set in, some senior directors still hold more board seats than allowed.
Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.
Company aims to build five Rs 100 cr-plus brands and launch products from South African arm in domestic market
We present our alphabet of 2020, pulling in everything you'll remember about this year we'd rather forget.
The letter was the latest sign of US frustration about the business environment in India.
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
The NSE 50-share Nifty spurted 97.25 points, or 0.92 per cent, to 10,715.50
The Finance Ministry further said decision on seven FDI proposals has been deferred.
'The obvious opportunity is biosimilars, which are simpler but more expensive,' says Kiran Mazumdar-Shaw, founder of Biocon.
The government has cleared 19 foreign investment proposals, including that of Walt Disney Company and Reckitt Benckiser (India), entailing total investment of Rs 2,326.72 crore (Rs 23.26 billion).
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.
Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.
Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.
Launches cloud-based version of solution to target mid-size clients in life sciences.
It's a post-truth world for multinational brands and businesses too.
The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.
Sources indicated defence and national security initiatives.
'India missed the software products revolution (and now is in danger of missing the platform revolution), complacent that we are the software experts of the world based on IT services prowess,' points out Rajeev Srinivasan.
The Indian government headed by Prime Minister Manmohan Singh, who is known as the architect of the country's liberalisation and economic reforms, is inching towards a "protectionist" regime, top American experts have told US lawmakers.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances